Table 6. Allele and genotype frequency for IS patients and healthy controls.
SNP | IS patients N = 287 | HWE | Healthy controls N = 182 | HWE | p value a dominantb | p value a recessivec | p value a allele de-pendent | Odds ratio (95% CI) | ||
XbaI | Genotype | AA | 33.5% (96) | 33.5% (61) | ||||||
AG | 49.1% (141) | 0.89 | 50.5% (92) | 0.56 | 0.7696 | 0.9880 | 0.3685 | 0.90 (0.54–1.48)** | ||
GG | 17.4% (50) | 15.9% (29) | 0.99 (0.67–1.48)*** | |||||||
Allele | A | 58.0% (333) | 58.8% (214) | |||||||
G | 42.0% (241) | 41.2% (150) | 0.8671 | 0.97 (0.74–1.26) | ||||||
PvuII | Genotype | TT | 26.8% (77) | 23.1% (42) | ||||||
TC | 50.2% (144) | 0.93 | 51.1% (93) | 0.76 | 0.5572 | 0.4230 | 0.6046 | 1.17 (0.76–179)** | ||
CC | 23.0% (66) | 25.8% (47) | 1.22 (0.79–1.88)*** | |||||||
Allele | T | 51.9% (298) | 48.6% (177) | |||||||
C | 48.1% (276) | 51.4% (187) | 0.3601 | 0.14 (0.87–1.48) |
Chi2 test.
Dominant model contrasts: for XbaI XX and Xx vs xx, for PvuII PP and Pp vs pp.
Recessive model contrasts: for XabI XX vs Xx and xx, for PvuII PP vs Pp and pp.